Geert Kleinnibbelink

Chapter 1 30 32. Baggish AL, Battle RW, Beckerman JG, Bove AA, Lampert RJ, Levine BD, Link MS, Martinez MW, Molossi SM, Salerno J, Wasfy MM, Weiner RB, Emery MS, Sports ACs and Exercise Council Leadership G. Sports Cardiology: Core Curriculum for Providing Cardiovascular Care to Competitive Athletes and Highly Active People. J Am Coll Cardiol . 2017;70:1902-1918. 33. Messerli FH, Rimoldi SF and Bangalore S. The Transition From Hypertension to Heart Failure: Contemporary Update. JACC Heart Fail . 2017;5:543-551. 34. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk NoordegraafA, BeghettiM, Ghofrani A, GomezSanchezMA,HansmannG, KlepetkoW, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M and Group ESCSD. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis andTreatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J . 2016;37:67-119. 35. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM and Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol . 2013;62:D34-41. 36. Vonk Noordegraaf A, Westerhof BE and Westerhof N. The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. J Am Coll Cardiol . 2017;69:236-243. 37. Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD and Benza RL. Five-Year outcomes of patients enrolled in the REVEAL Registry. Chest . 2015;148:1043-54. 38. Haddad F, Spruijt OA, Denault AY, Mercier O, Brunner N, Furman D, Fadel E, Bogaard HJ, Schnittger I, Vrtovec B, Wu JC, de Jesus Perez V, Vonk-Noordegraaf A and Zamanian RT. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension. JACC Cardiovasc Imaging . 2015;8:627-38. 39. Artis NJ, Oxborough DL, Williams G, Pepper CB and Tan LB. Two-dimensional strain imaging: a new echocardiographic advance with research and clinical applications. Int J Cardiol . 2008;123:240-8. 40. Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK and Kane GC. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension. Circ Cardiovasc Imaging . 2013;6:711-21. 41. Giusca S, Jurcut R, Coman IM, Ghiorghiu I, Catrina D, Popescu BA, Dima L and Ginghina C. Right ventricular function predicts clinical response to specific vasodilator therapy in patients with pulmonary hypertension. Echocardiography . 2013;30:17-26. 42. Goda A, Ryo K, Delgado-Montero A, Tayal B, Handa R, Simon MA and Gorcsan J, 3rd. The Prognostic Utility of a Simplified Biventricular Echocardiographic Index of Cardiac Remodeling in Patients with Pulmonary Hypertension. J Am Soc Echocardiogr . 2016;29:554-60. 43. Haeck ML, Scherptong RW, Marsan NA, Holman ER, Schalij MJ, Bax JJ, Vliegen HW and Delgado V. Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension. Circ Cardiovasc Imaging . 2012;5:628-36.